The Bombay High Court quashes the Food and Drug Administration (FDA)’s suspension of a star hotel’s food licence, ruling that the measure is not justified by the findings of an inspection. According to the court, an earlier hygiene compliance report was overall satisfactory, and the presence of only two insects—when considered in that context—does not warrant continued suspension of the licence.
The case focuses on the FDA action following observations made during the hygiene review. The hotel’s challenge argues that the regulatory step was disproportionate to the inspection results. The court agrees, emphasizing that the detection of two insects, against the backdrop of broader compliance, cannot on its own sustain the suspension.
As a result, the court’s order sets aside the FDA’s suspension and removes the restriction on the hotel’s food licence. The decision underscores that regulatory enforcement should align with the overall inspection outcome rather than isolated findings.
